newsfilter
← Latest News
PR Newswire·

Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...